UNEEG Medical A/S
UNEEG medical is a pioneering company specializing in providing the epilepsy community with more accurate seizure data through innovative subcutaneous EEG solutions. Founded in 2005 in Denmark, the company aims to improve epilepsy care and patients' quality of life by offering long-term, objective, and longitudinal EEG monitoring technology. Their flagship product, UNEEG EpiSight, enables continuous EEG recording during everyday life, supporting better diagnostics, treatment assessment, and patient empowerment.
Industries
Nr. of Employees
small (1-50)
UNEEG Medical A/S
Patents
Products
Implantable subcutaneous EEG sensor (three-electrode)
A minimally invasive subcutaneous EEG sensing unit with multiple electrodes designed for long-term implantation to capture continuous EEG in ambulatory patients.
Wearable recorder for ambulatory EEG
A wireless recorder that retrieves EEG from the implanted sensor, stores data locally with multi-day battery life and transmits data to analysis systems or paired mobile devices.
Mobile application for recorder management and event logging
Smartphone application allowing users to manage the ambulatory recorder, log self-reported seizures and synchronize events with recorded EEG data.
AI analytics platform for long-duration EEG
Proprietary analytics software that processes long-term EEG to detect suspected seizures, perform sleep staging, summarize seizure burden and provide clinician-ready summaries and access to raw data.
Implantable subcutaneous EEG sensor (three-electrode)
A minimally invasive subcutaneous EEG sensing unit with multiple electrodes designed for long-term implantation to capture continuous EEG in ambulatory patients.
Wearable recorder for ambulatory EEG
A wireless recorder that retrieves EEG from the implanted sensor, stores data locally with multi-day battery life and transmits data to analysis systems or paired mobile devices.
Mobile application for recorder management and event logging
Smartphone application allowing users to manage the ambulatory recorder, log self-reported seizures and synchronize events with recorded EEG data.
AI analytics platform for long-duration EEG
Proprietary analytics software that processes long-term EEG to detect suspected seizures, perform sleep staging, summarize seizure burden and provide clinician-ready summaries and access to raw data.
Services
Automated processing of long-duration EEG recordings to detect suspected seizure activity, correlate with sleep and patient-reported events, and generate concise clinician-ready reports; provides access to raw and analyzed data for review.
Clinical workflow and review service enabling fast clinician assessment of AI-highlighted EEG events and generation of clinical summaries to inform management decisions.
Provision of ultra long-term ambulatory EEG data, analytic methods and collaboration resources to support clinical studies, publications, and use of EEG endpoints in drug development.
Automated processing of long-duration EEG recordings to detect suspected seizure activity, correlate with sleep and patient-reported events, and generate concise clinician-ready reports; provides access to raw and analyzed data for review.
Clinical workflow and review service enabling fast clinician assessment of AI-highlighted EEG events and generation of clinical summaries to inform management decisions.
Provision of ultra long-term ambulatory EEG data, analytic methods and collaboration resources to support clinical studies, publications, and use of EEG endpoints in drug development.
Expertise Areas
- Ultra long-term ambulatory EEG monitoring
- Epilepsy monitoring and management
- EEG data analytics and AI-driven seizure detection
- Automated sleep staging from EEG
Key Technologies
- Subcutaneous implantable EEG sensors (multi-electrode)
- Wireless ambulatory EEG recorders
- Mobile apps for event capture and device management
- AI-based signal analysis and seizure detection
News & Updates
On June 11, 2025, UNEEG medical announced EU approval for the 3-year continuous use of its subcutaneous implant, strengthening its epilepsy monitoring solution.
Martin Stenfeldt became the new CEO on March 7, 2025, succeeding Torben Sandgren.
On November 22, 2024, UNEEG received FDA Breakthrough Device Designation for its innovative epilepsy monitoring tools.
An article discussing the importance and benefits of ultra long-term EEG monitoring in epilepsy management.
A study comparing the quality of subcutaneous EEG recordings with traditional scalp electrodes.
Research on predicting seizures with individualized models based on long-term subcutaneous EEG data.
On June 11, 2025, UNEEG medical announced EU approval for the 3-year continuous use of its subcutaneous implant, strengthening its epilepsy monitoring solution.
Martin Stenfeldt became the new CEO on March 7, 2025, succeeding Torben Sandgren.
On November 22, 2024, UNEEG received FDA Breakthrough Device Designation for its innovative epilepsy monitoring tools.
An article discussing the importance and benefits of ultra long-term EEG monitoring in epilepsy management.
A study comparing the quality of subcutaneous EEG recordings with traditional scalp electrodes.
Research on predicting seizures with individualized models based on long-term subcutaneous EEG data.